One-month lemborexant dosing for moderate sleep apnea
Treatments studied
Part of Brain & nervous system, Lungs & breathing clinical trials.
This study tests a sleep medication called lemborexant in people with moderate sleep apnea and a specific pattern called 'low arousal threshold.' The goal is to find the best one-month dose to help them sleep better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have moderate sleep apnea (confirmed by a sleep study with 15 to 30 breathing pauses per hour).
- You have a specific pattern called 'low arousal threshold' that makes you wake up easily from breathing pauses.
- You usually sleep at least 5.5 hours each night, and your bedtime is between 9 PM and 1 AM.
- You are not pregnant or breastfeeding and are in general good health.
- You are not using any CPAP machine or mouth device for sleep apnea.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests two sleep medications, eszopiclone and lemborexant, to see if they can improve sleep quality in people who have both obstructive sleep apnea (where breathing stops during sleep) and trouble falling or staying asleep. It may help if you have mild sleep apnea and a low threshold for waking up easily.
This study tests if lemborexant, a sleep medication, can help people with both a mental health condition and insomnia. You would take the medicine as prescribed and complete questionnaires over 2 months.
This study is testing whether a sleep medication called lemborexant can improve sleep and reduce Alzheimer's-related proteins in healthy older adults with no memory problems. It could help find new ways to delay or prevent Alzheimer's disease.
This study tests a sleep medication, lemborexant, to see if it helps reduce the number of times older adults wake up at night to urinate. It may improve sleep quality and reduce bother from nighttime urination.
This study tests if the sleep medication lemborexant can help people with opioid use disorder who also have chronic insomnia. Participants must already be taking buprenorphine (Suboxone) for at least 4 weeks. The goal is to see if better sleep improves mood and reduces opioid use.
This study tests a new sleep medicine called lemborexant for people with epilepsy whose seizures happen during sleep and who also have trouble sleeping. The goal is to see if the medicine can help you sleep better without making your seizures worse.
Hear when a new OSA - Obstructive Sleep Apnea trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.